2015-2027 Global Antidiabetic Drug Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

May 2020 | 140 pages | ID: 2E7DB08FC514EN
Maia Research

Abstracts

The worldwide market for Antidiabetic Drug is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Halozyme Therapeutics
Novo Nordisk
Boehringer Ingelheim
Sanofi-Aventis
Eli Lilly
Takeda
Wockhardt
Oramed
Tonghua Dongbao
Biocon
Bristol-Myers Squibb
Pfizer

Major Types Covered
Alpha-Glucosidase Inhibitors
Biguanides, Sulphonylureas
Glp-1 Agonist
Meglitinides
Dpp-4 Inhibitors
Sglt-2
Thiazolidinediones
Other

Major Applications Covered
Type I Diabetes
Type II Diabetes
Other

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Antidiabetic Drug Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Antidiabetic Drug Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE ANTIDIABETIC DRUG MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL ANTIDIABETIC DRUG MARKET-SEGMENTATION BY TYPE

5.1 Alpha-Glucosidase Inhibitors
5.2 Biguanides, Sulphonylureas
5.3 Glp-1 Agonist
5.4 Meglitinides
5.5 Dpp-4 Inhibitors
5.6 Sglt-2
5.7 Thiazolidinediones
5.8 Other

6 GLOBAL ANTIDIABETIC DRUG MARKET-SEGMENTATION BY APPLICATION

6.1 Type I Diabetes
6.2 Type II Diabetes
6.3 Other

7 GLOBAL ANTIDIABETIC DRUG MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Halozyme Therapeutics
  8.1.1 Halozyme Therapeutics Profile
  8.1.2 Halozyme Therapeutics Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Halozyme Therapeutics Product/Solution Launches and Enhancements Analysis
  8.1.4 Halozyme Therapeutics Business Overview/Recent Development/Acquisitions
8.2 Novo Nordisk
  8.2.1 Novo Nordisk Profile
  8.2.2 Novo Nordisk Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Novo Nordisk Product/Solution Launches and Enhancements Analysis
  8.2.4 Novo Nordisk Business Overview/Recent Development/Acquisitions
8.3 Boehringer Ingelheim
  8.3.1 Boehringer Ingelheim Profile
  8.3.2 Boehringer Ingelheim Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Boehringer Ingelheim Product/Solution Launches and Enhancements Analysis
  8.3.4 Boehringer Ingelheim Business Overview/Recent Development/Acquisitions
8.4 Sanofi-Aventis
  8.4.1 Sanofi-Aventis Profile
  8.4.2 Sanofi-Aventis Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Sanofi-Aventis Product/Solution Launches and Enhancements Analysis
  8.4.4 Sanofi-Aventis Business Overview/Recent Development/Acquisitions
8.5 Eli Lilly
  8.5.1 Eli Lilly Profile
  8.5.2 Eli Lilly Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Eli Lilly Product/Solution Launches and Enhancements Analysis
  8.5.4 Eli Lilly Business Overview/Recent Development/Acquisitions
8.6 Takeda
  8.6.1 Takeda Profile
  8.6.2 Takeda Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Takeda Product/Solution Launches and Enhancements Analysis
  8.6.4 Takeda Business Overview/Recent Development/Acquisitions
8.7 Wockhardt
  8.7.1 Wockhardt Profile
  8.7.2 Wockhardt Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Wockhardt Product/Solution Launches and Enhancements Analysis
  8.7.4 Wockhardt Business Overview/Recent Development/Acquisitions
8.8 Oramed
  8.8.1 Oramed Profile
  8.8.2 Oramed Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Oramed Product/Solution Launches and Enhancements Analysis
  8.8.4 Oramed Business Overview/Recent Development/Acquisitions
8.9 Tonghua Dongbao
  8.9.1 Tonghua Dongbao Profile
  8.9.2 Tonghua Dongbao Sales, Growth Rate and Global Market Share from 2015-2020
  8.9.3 Tonghua Dongbao Product/Solution Launches and Enhancements Analysis
  8.9.4 Tonghua Dongbao Business Overview/Recent Development/Acquisitions
8.10 Biocon
  8.10.1 Biocon Profile
  8.10.2 Biocon Sales, Growth Rate and Global Market Share from 2015-2020
  8.10.3 Biocon Product/Solution Launches and Enhancements Analysis
  8.10.4 Biocon Business Overview/Recent Development/Acquisitions
8.11 Bristol-Myers Squibb
  8.11.1 Bristol-Myers Squibb Profile
  8.11.2 Bristol-Myers Squibb Sales, Growth Rate and Global Market Share from 2015-2020
  8.11.3 Bristol-Myers Squibb Product/Solution Launches and Enhancements Analysis
  8.11.4 Bristol-Myers Squibb Business Overview/Recent Development/Acquisitions
8.12 Pfizer
  8.12.1 Pfizer Profile
  8.12.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
  8.12.3 Pfizer Product/Solution Launches and Enhancements Analysis
  8.12.4 Pfizer Business Overview/Recent Development/Acquisitions

9 GLOBAL ANTIDIABETIC DRUG MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Antidiabetic Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Antidiabetic Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Antidiabetic Drug Production Analysis from 2015-2020
10.4 North America Antidiabetic Drug Consumption Analysis from 2015-2020
10.5 North America Antidiabetic Drug Import and Export from 2015-2020
10.6 North America Antidiabetic Drug Value, Production and Market Share by Type (2015-2020)
10.7 North America Antidiabetic Drug Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Antidiabetic Drug by Country (United States, Canada)
  10.8.1 North America Antidiabetic Drug Sales by Country (2015-2020)
  10.8.2 North America Antidiabetic Drug Consumption Value by Country (2015-2020)
10.9 North America Antidiabetic Drug Market PEST Analysis

11 EUROPE

11.1 Europe Antidiabetic Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Antidiabetic Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Antidiabetic Drug Production Analysis from 2015-2020
11.4 Europe Antidiabetic Drug Consumption Analysis from 2015-2020
11.5 Europe Antidiabetic Drug Import and Export from 2015-2020
11.6 Europe Antidiabetic Drug Value, Production and Market Share by Type (2015-2020)
11.7 Europe Antidiabetic Drug Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Antidiabetic Drug by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Antidiabetic Drug Sales by Country (2015-2020)
  11.8.2 Europe Antidiabetic Drug Consumption Value by Country (2015-2020)
11.9 Europe Antidiabetic Drug Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Antidiabetic Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Antidiabetic Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Antidiabetic Drug Production Analysis from 2015-2020
12.4 Asia-Pacific Antidiabetic Drug Consumption Analysis from 2015-2020
12.5 Asia-Pacific Antidiabetic Drug Import and Export from 2015-2020
12.6 Asia-Pacific Antidiabetic Drug Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Antidiabetic Drug Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Antidiabetic Drug by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Antidiabetic Drug Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Antidiabetic Drug Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Antidiabetic Drug Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Antidiabetic Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Antidiabetic Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Antidiabetic Drug Production Analysis from 2015-2020
13.4 Latin America Antidiabetic Drug Consumption Analysis from 2015-2020
13.5 Latin America Antidiabetic Drug Import and Export from 2015-2020
13.6 Latin America Antidiabetic Drug Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Antidiabetic Drug Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Antidiabetic Drug by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Antidiabetic Drug Sales by Country (2015-2020)
  13.8.2 Latin America Antidiabetic Drug Consumption Value by Country (2015-2020)
13.9 Latin America Antidiabetic Drug Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Antidiabetic Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Antidiabetic Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Antidiabetic Drug Production Analysis from 2015-2020
14.4 Middle East & Africa Antidiabetic Drug Consumption Analysis from 2015-2020
14.5 Middle East & Africa Antidiabetic Drug Import and Export from 2015-2020
14.6 Middle East & Africa Antidiabetic Drug Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Antidiabetic Drug Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Antidiabetic Drug by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Antidiabetic Drug Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Antidiabetic Drug Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Antidiabetic Drug Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL ANTIDIABETIC DRUG MARKET FROM 2020-2027

15.1 Future Forecast of the Global Antidiabetic Drug Market from 2020-2027 Segment by Region
15.2 Global Antidiabetic Drug Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Antidiabetic Drug Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Antidiabetic Drug Market Value ($) and Growth Rate of Antidiabetic Drug from 2015-2027
Global Antidiabetic Drug Production and Growth Rate Segment by Product Type from 2015-2027
Global Antidiabetic Drug Consumption and Growth Rate Segment by Application from 2015-2027
Figure Antidiabetic Drug Picture
Table Product Specifications of Antidiabetic Drug
Table Driving Factors for this Market
Table Industry News of Antidiabetic Drug Market
Figure Value Chain Status of Antidiabetic Drug
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Antidiabetic Drug Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Antidiabetic Drug Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Alpha-Glucosidase Inhibitors of Antidiabetic Drug
Figure Biguanides, Sulphonylureas of Antidiabetic Drug
Figure Glp-1 Agonist of Antidiabetic Drug
Figure Meglitinides of Antidiabetic Drug
Figure Dpp-4 Inhibitors of Antidiabetic Drug
Figure Sglt-2 of Antidiabetic Drug
Figure Thiazolidinediones of Antidiabetic Drug
Figure Other of Antidiabetic Drug
Table Global Antidiabetic Drug Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Antidiabetic Drug Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Type I Diabetes of Antidiabetic Drug
Figure Type II Diabetes of Antidiabetic Drug
Figure Other of Antidiabetic Drug
Table Global Antidiabetic Drug Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Antidiabetic Drug Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Antidiabetic Drug
Figure Online Channel of Antidiabetic Drug
Table Halozyme Therapeutics Profile (Company Name, Plants Distribution, Sales Region)
Figure Halozyme Therapeutics Sales and Growth Rate from 2015-2020
Figure Halozyme Therapeutics Revenue ($) and Global Market Share from 2015-2020
Table Halozyme Therapeutics Antidiabetic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novo Nordisk Profile (Company Name, Plants Distribution, Sales Region)
Figure Novo Nordisk Sales and Growth Rate from 2015-2020
Figure Novo Nordisk Revenue ($) and Global Market Share from 2015-2020
Table Novo Nordisk Antidiabetic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Boehringer Ingelheim Profile (Company Name, Plants Distribution, Sales Region)
Figure Boehringer Ingelheim Sales and Growth Rate from 2015-2020
Figure Boehringer Ingelheim Revenue ($) and Global Market Share from 2015-2020
Table Boehringer Ingelheim Antidiabetic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sanofi-Aventis Profile (Company Name, Plants Distribution, Sales Region)
Figure Sanofi-Aventis Sales and Growth Rate from 2015-2020
Figure Sanofi-Aventis Revenue ($) and Global Market Share from 2015-2020
Table Sanofi-Aventis Antidiabetic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Eli Lilly Profile (Company Name, Plants Distribution, Sales Region)
Figure Eli Lilly Sales and Growth Rate from 2015-2020
Figure Eli Lilly Revenue ($) and Global Market Share from 2015-2020
Table Eli Lilly Antidiabetic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Takeda Profile (Company Name, Plants Distribution, Sales Region)
Figure Takeda Sales and Growth Rate from 2015-2020
Figure Takeda Revenue ($) and Global Market Share from 2015-2020
Table Takeda Antidiabetic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Wockhardt Profile (Company Name, Plants Distribution, Sales Region)
Figure Wockhardt Sales and Growth Rate from 2015-2020
Figure Wockhardt Revenue ($) and Global Market Share from 2015-2020
Table Wockhardt Antidiabetic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Oramed Profile (Company Name, Plants Distribution, Sales Region)
Figure Oramed Sales and Growth Rate from 2015-2020
Figure Oramed Revenue ($) and Global Market Share from 2015-2020
Table Oramed Antidiabetic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Tonghua Dongbao Profile (Company Name, Plants Distribution, Sales Region)
Figure Tonghua Dongbao Sales and Growth Rate from 2015-2020
Figure Tonghua Dongbao Revenue ($) and Global Market Share from 2015-2020
Table Tonghua Dongbao Antidiabetic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Biocon Profile (Company Name, Plants Distribution, Sales Region)
Figure Biocon Sales and Growth Rate from 2015-2020
Figure Biocon Revenue ($) and Global Market Share from 2015-2020
Table Biocon Antidiabetic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Bristol-Myers Squibb Profile (Company Name, Plants Distribution, Sales Region)
Figure Bristol-Myers Squibb Sales and Growth Rate from 2015-2020
Figure Bristol-Myers Squibb Revenue ($) and Global Market Share from 2015-2020
Table Bristol-Myers Squibb Antidiabetic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Antidiabetic Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Antidiabetic Drug Production Value ($) by Region from 2015-2020
Table Global Antidiabetic Drug Production Value Share by Region from 2015-2020
Table Global Antidiabetic Drug Production by Region from 2015-2020
Table Global Antidiabetic Drug Consumption Value ($) by Region from 2015-2020
Table Global Antidiabetic Drug Consumption by Region from 2015-2020
Table North America Antidiabetic Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Antidiabetic Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Antidiabetic Drug Import and Export from 2015-2020
Table North America Antidiabetic Drug Value ($) by Type (2015-2020)
Table North America Antidiabetic Drug Production by Type (2015-2020)
Table North America Antidiabetic Drug Consumption by Application (2015-2020)
Table North America Antidiabetic Drug Consumption by Country (2015-2020)
Table North America Antidiabetic Drug Consumption Value ($) by Country (2015-2020)
Figure North America Antidiabetic Drug Market PEST Analysis
Table Europe Antidiabetic Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Antidiabetic Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Antidiabetic Drug Import and Export from 2015-2020
Table Europe Antidiabetic Drug Value ($) by Type (2015-2020)
Table Europe Antidiabetic Drug Production by Type (2015-2020)
Table Europe Antidiabetic Drug Consumption by Application (2015-2020)
Table Europe Antidiabetic Drug Consumption by Country (2015-2020)
Table Europe Antidiabetic Drug Consumption Value ($) by Country (2015-2020)
Figure Europe Antidiabetic Drug Market PEST Analysis
Table Asia-Pacific Antidiabetic Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Antidiabetic Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Antidiabetic Drug Import and Export from 2015-2020
Table Asia-Pacific Antidiabetic Drug Value ($) by Type (2015-2020)
Table Asia-Pacific Antidiabetic Drug Production by Type (2015-2020)
Table Asia-Pacific Antidiabetic Drug Consumption by Application (2015-2020)
Table Asia-Pacific Antidiabetic Drug Consumption by Country (2015-2020)
Table Asia-Pacific Antidiabetic Drug Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Antidiabetic Drug Market PEST Analysis
Table Latin America Antidiabetic Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Antidiabetic Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Antidiabetic Drug Import and Export from 2015-2020
Table Latin America Antidiabetic Drug Value ($) by Type (2015-2020)
Table Latin America Antidiabetic Drug Production by Type (2015-2020)
Table Latin America Antidiabetic Drug Consumption by Application (2015-2020)
Table Latin America Antidiabetic Drug Consumption by Country (2015-2020)
Table Latin America Antidiabetic Drug Consumption Value ($) by Country (2015-2020)
Figure Latin America Antidiabetic Drug Market PEST Analysis
Table Middle East & Africa Antidiabetic Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Antidiabetic Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Antidiabetic Drug Import and Export from 2015-2020
Table Middle East & Africa Antidiabetic Drug Value ($) by Type (2015-2020)
Table Middle East & Africa Antidiabetic Drug Production by Type (2015-2020)
Table Middle East & Africa Antidiabetic Drug Consumption by Application (2015-2020)
Table Middle East & Africa Antidiabetic Drug Consumption by Country (2015-2020)
Table Middle East & Africa Antidiabetic Drug Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Antidiabetic Drug Market PEST Analysis
Table Global Antidiabetic Drug Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Antidiabetic Drug Production and Growth Rate Forecast by Region (2020-2027)
Table Global Antidiabetic Drug Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Antidiabetic Drug Production and Growth Rate Forecast by Type (2020-2027)
Table Global Antidiabetic Drug Consumption and Growth Rate Forecast by Application (2020-2027)